Codes / ICD10CM / C50.319

C50.319 Malignant neoplasm of lower-inner quadrant of unspecified female breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant Neoplasm of Lower-Inner Quadrant of Unspecified Female Breast
  • Breast Cancer, Lower-Inner Quadrant (Unspecified Breast, Female)

Summary

Malignant neoplasm of the lower-inner quadrant of the unspecified female breast refers to a type of breast cancer originating in the lower-inner region of breast tissue in females. It involves the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body.

Causes

The exact causes are not fully understood, but breast cancer generally arises from genetic mutations and cellular changes. Factors such as inherited gene mutations (e.g., BRCA1/BRCA2), hormonal influences, and environmental exposures may contribute to its development.

Risk Factors

  • Age (increased risk in older individuals)
  • Family history of breast cancer
  • Genetic predispositions (e.g., BRCA mutations)
  • Previous breast cancer diagnosis
  • Hormonal factors (e.g., early menstruation, late menopause)
  • Lifestyle factors (e.g., obesity, alcohol consumption)

Symptoms

  • A new lump or mass in the breast
  • Changes in breast shape or size
  • Dimpling or puckering of breast skin
  • Nipple discharge, inversion, or changes
  • Redness, scaliness, or thickening of breast or nipple skin

Diagnosis

Diagnosis typically involves a combination of clinical examination, imaging studies (mammography, ultrasound, MRI), and tissue biopsy to confirm the presence of malignant cells. Additional tests may be performed to determine the cancer's stage and characteristics.

Treatment Options

Treatment depends on the cancer's stage, type, and patient factors. Options may include surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, targeted therapy, or immunotherapy. A multidisciplinary approach is often used to tailor treatment.

Prognosis and Follow-Up

Prognosis varies based on the cancer's stage, grade, and molecular features. Regular follow-up care, including imaging and clinical exams, is essential to monitor for recurrence or progression. Long-term survival rates depend on early detection and appropriate treatment.

Complications

Complications may include lymphedema, infection, metastasis to other organs, treatment-related side effects (e.g., fatigue, nausea), and emotional or psychological distress. Advanced disease can lead to organ dysfunction or reduced quality of life.

Lifestyle & Prevention

  • Maintain a healthy weight and balanced diet
  • Limit alcohol consumption
  • Engage in regular physical activity
  • Avoid tobacco use
  • Consider genetic counseling if high risk
  • Follow recommended breast cancer screening guidelines

When to Seek Professional Help

Seek medical attention if you notice new breast lumps, skin changes, nipple discharge, or persistent pain. Early evaluation is critical for timely diagnosis and treatment. Contact a healthcare provider for any concerning symptoms or changes.

Tips for Medical Coders

Use C50.319 for malignant neopasm of the lower-inner quadrant of the unspecified female breast. Document the breast laterality as unspecified when the medical record does not specify left or right. Ensure the diagnosis aligns with clinical findings and imaging results. Verify that the code is not used if laterality is documented elsewhere.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C50.319 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.